Minhchau T Nguyen, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Nguyen’s office at (408) 885-5110 to ask if they take your plan before you enroll.
California Medical Board record
Licence A105080 · Current
Licensed to practise in California · since 2008 · expires 2028-08-31 · Umdnj Robert Wood Johnson Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Rheumatology
Medicaid work
$3,265 in 2023
Medicaid paid $3,265 for 42 billed services this clinician did in 2023, up to 42 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 42 | $3,265 |
| 2023 | 42 | 1 | 42 | $3,265 |
| 2022 | 48 | 1 | 20 | $2,805 |
| 2018 | 12 | 1 | 12 | $0 |
See the largest Medicaid services in earlier years
2022
| Short return visit (20+ min) | 48 | $2,805 |
2018
| Return visit (30+ min) | 12 | $0 |
Drugs they prescribed that Part D paid
$6,191
Pharmacies billed $6,191 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 74% of their Part D prescriptions (40 of 54) in 2024. A higher opioid share than 9 in 10 peers; the typical rheumatology clinician is at 3%.
51 generic and fewer than 11 brand-name prescriptions · $6,191 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 14 | $661 | $19 |
Year by year
| 2024 | 54 | 19 | 74% (40) | None | $6,191 |
| 2023 | 35 | 16 | 83% (29) | None | $1,178 |
| 2022 | 42 | 21 | 60% (25) | None | $12,198 |
| 2021 | 300 | 236 | 9% (28) | None | $133,028 |
| 2020 | 890 | 164 | None | 28% | $710,484 |
| 2019 | 957 | 159 | 1% (11) | None | $864,217 |
| 2018 | 1,022 | 163 | 1% (11) | None | $896,687 |
| 2017 | 842 | 186 | 2% (19) | None | $774,870 |
| 2016 | 677 | 192 | 9% (62) | 32% | $493,173 |
| 2015 | 493 | 180 | 15% (72) | None | $192,323 |
| 2014 | 162 | 66 | 7% (12) | 31% | $31,175 |
| 2013 | 123 | 47 | None | 33% | $32,272 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Hydrocodone-Acetaminophen | 19 | $265 | $14 |
2022: 1 drug
| Hydrocodone-Acetaminophen | 19 | $290 | $15 |
2021: 6 drugs
| Hydroxychloroquine Sulfate | 41 | $2,033 | $50 |
| Methotrexate | 58 | $1,393 | $24 |
| Prednisone | 35 | $832 | $24 |
| Leucovorin | 24 | $795 | $33 |
| Leflunomide | 13 | $729 | $56 |
| Hydrocodone-Acetaminophen | 22 | $400 | $18 |
2020: 19 drugs
| Enbrel Sureclick | 28 | $129,856 | $4,638 |
| Humira | 30 | $124,763 | $4,159 |
| Xeljanz | 33 | $89,956 | $2,726 |
| Humira | 17 | $70,618 | $4,154 |
| Actemra | 24 | $64,849 | $2,702 |
| Enbrel | 13 | $59,899 | $4,608 |
| Humira(Cf) | 14 | $58,092 | $4,149 |
| Cosentyx Pen (2 Pens) | 14 | $51,762 | $3,697 |
| Hydroxychloroquine Sulfate | 96 | $4,743 | $49 |
| Methotrexate | 160 | $4,552 | $28 |
| Prednisone | 153 | $4,092 | $27 |
| Colchicine | 12 | $3,490 | $291 |
| Leucovorin | 101 | $3,009 | $30 |
| Mycophenolate Mofetil | 16 | $2,007 | $125 |
| Leflunomide | 24 | $1,430 | $60 |
| Allopurinol | 29 | $915 | $32 |
| Diclofenac | 12 | $719 | $60 |
| Alendronate | 20 | $208 | $10 |
| Veo Insulin | 20 | $60 | $3 |
2019: 18 drugs
| Humira | 47 | $189,994 | $4,042 |
| Enbrel Sureclick | 34 | $146,091 | $4,297 |
| Humira | 29 | $137,856 | $4,754 |
| Enbrel | 13 | $55,564 | $4,274 |
| Actemra | 16 | $48,645 | $3,040 |
| Cosentyx Pen (2 Pens) | 12 | $47,075 | $3,923 |
| Xeljanz | 15 | $34,319 | $2,288 |
| Uloric | 17 | $21,641 | $1,273 |
| Hydroxychloroquine Sulfate | 54 | $7,216 | $134 |
| Colchicine | 18 | $5,796 | $322 |
| Prednisone | 190 | $5,364 | $28 |
| Leflunomide | 42 | $5,147 | $123 |
| Methotrexate | 177 | $4,865 | $27 |
| Mycophenolate Mofetil | 19 | $4,237 | $223 |
| Leucovorin | 91 | $2,141 | $24 |
| Allopurinol | 32 | $1,321 | $41 |
| Alendronate | 30 | $367 | $12 |
| Hydrocodone-Acetaminophen | 11 | $257 | $23 |
2018: 21 drugs
| Humira | 41 | $161,037 | $3,928 |
| Humira | 30 | $129,851 | $4,328 |
| Enbrel | 28 | $119,236 | $4,258 |
| Enbrel Sureclick | 19 | $82,516 | $4,343 |
| Xeljanz Xr | 23 | $79,148 | $3,441 |
| Simponi | 12 | $57,790 | $4,816 |
| Cosentyx Pen (2 Pens) | 13 | $47,188 | $3,630 |
| Xeljanz | 12 | $39,059 | $3,255 |
| Uloric | 30 | $39,004 | $1,300 |
| Leflunomide | 39 | $13,677 | $351 |
| Methotrexate | 186 | $12,294 | $66 |
| Colchicine | 28 | $10,597 | $378 |
| Prednisone | 217 | $5,277 | $24 |
| Hydroxychloroquine Sulfate | 74 | $4,998 | $68 |
| Mycophenolate Mofetil | 16 | $3,357 | $210 |
| Allopurinol | 55 | $2,339 | $43 |
| Azathioprine | 11 | $1,568 | $143 |
| Leucovorin | 53 | $1,017 | $19 |
| Sulfasalazine | 11 | $824 | $75 |
| Alendronate | 43 | $542 | $13 |
| Hydrocodone-Acetaminophen | 11 | $281 | $26 |
2017: 17 drugs
| Humira | 55 | $203,363 | $3,698 |
| Enbrel Sureclick | 28 | $110,331 | $3,940 |
| Humira | 22 | $81,129 | $3,688 |
| Enbrel | 19 | $75,171 | $3,956 |
| Simponi | 15 | $56,914 | $3,794 |
| Xeljanz | 17 | $53,231 | $3,131 |
| Uloric | 27 | $32,919 | $1,219 |
| Mycophenolate Mofetil | 18 | $15,219 | $845 |
| Methotrexate | 142 | $8,598 | $61 |
| Colchicine | 28 | $8,437 | $301 |
| Leflunomide | 22 | $6,697 | $304 |
| Hydroxychloroquine Sulfate | 63 | $5,539 | $88 |
| Prednisone | 192 | $4,977 | $26 |
| Sulfasalazine | 15 | $2,160 | $144 |
| Allopurinol | 37 | $1,729 | $47 |
| Hydrocodone-Acetaminophen | 18 | $631 | $35 |
| Alendronate | 22 | $313 | $14 |
2016: 14 drugs
| Humira | 44 | $150,018 | $3,410 |
| Enbrel | 27 | $97,768 | $3,621 |
| Simponi | 12 | $47,528 | $3,961 |
| Xeljanz | 12 | $42,381 | $3,532 |
| Uloric | 14 | $18,317 | $1,308 |
| Hydroxychloroquine Sulfate | 53 | $15,269 | $288 |
| Methotrexate | 116 | $6,755 | $58 |
| Prednisone | 159 | $6,305 | $40 |
| Colchicine | 20 | $5,136 | $257 |
| Hydrocodone-Acetaminophen | 28 | $1,961 | $70 |
| Allopurinol | 25 | $1,551 | $62 |
| Sulfasalazine | 12 | $1,070 | $89 |
| Alendronate | 24 | $907 | $38 |
| Morphine Sulfate Er | 16 | $663 | $41 |
2015: 13 drugs
| Enbrel | 27 | $76,762 | $2,843 |
| Humira | 11 | $30,152 | $2,741 |
| Hydroxychloroquine Sulfate | 29 | $5,557 | $192 |
| Colchicine | 13 | $3,741 | $288 |
| Prednisone | 95 | $3,198 | $34 |
| Methotrexate | 68 | $2,962 | $44 |
| Mycophenolate Mofetil | 13 | $2,554 | $196 |
| Hydrocodone-Acetaminophen | 27 | $1,842 | $68 |
| Allopurinol | 18 | $1,284 | $71 |
| Morphine Sulfate Er | 15 | $954 | $64 |
| Ibuprofen | 12 | $307 | $26 |
| Alendronate | 14 | $193 | $14 |
| Tramadol | 15 | $169 | $11 |
2014: 4 drugs
| Colcrys | 20 | $5,303 | $265 |
| Methotrexate | 12 | $1,005 | $84 |
| Gabapentin | 12 | $524 | $44 |
| Prednisone | 31 | $497 | $16 |
2013: 3 drugs
| Methotrexate | 20 | $1,176 | $59 |
| Prednisone | 20 | $197 | $10 |
| Hydroxychloroquine Sulfate | 11 | $177 | $16 |
Professional record
- NPI
- 1578729232
- Licence
- CA A105080California A105080: Current · expires 2028-08-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 751 S Bascom Ave, San Jose, CA, 95128
- NPI first listed
- 2008-08-01
- NPI last updated
- 2022-02-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.